Ted Cohen Selected Research

Isoniazid (Ftivazide)

1/2022	Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis.
12/2020	Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi.
1/2020	Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis.
10/2019	Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study.
1/2018	Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model.
1/2018	Protective effects of household-based TB interventions are robust to neighbourhood-level variation in exposure risk in Lima, Peru: a model-based analysis.
1/2018	Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study.
11/2016	Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
11/2016	Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.
6/2015	How could preventive therapy affect the prevalence of drug resistance? Causes and consequences.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ted Cohen Research Topics

Disease

43	Tuberculosis (Tuberculoses) 01/2022 - 01/2003
14	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 01/2003
13	Infections 06/2022 - 01/2007
8	Coinfection 11/2018 - 01/2009
6	Extensively Drug-Resistant Tuberculosis 12/2017 - 08/2010
3	Malaria 01/2021 - 06/2015
3	Human Influenza (Influenza) 10/2018 - 01/2007
3	Latent Tuberculosis 10/2014 - 05/2006
2	COVID-19 06/2022 - 01/2022
2	Gonorrhea 01/2022 - 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Disease Progression 10/2019
1	Weight Gain 11/2018
1	Meningitis 01/2018
1	Neoplasms (Cancer) 01/2017
1	Cholera 01/2017
1	Bacterial Infections (Bacterial Infection) 05/2015
1	Schistosomiasis (Bilharziasis) 01/2014
1	Communicable Diseases (Infectious Diseases) 06/2010
1	Lung Diseases (Lung Disease) 06/2008
1	Otitis Media 04/2008

Drug/Important Bio-Agent (IBA)

33	Pharmaceutical PreparationsIBA 01/2022 - 01/2003
18	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022 - 01/2004
12	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 06/2010
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2003
5	VaccinesIBA 01/2022 - 10/2008
3	Tuberculin (PPD)IBA 10/2019 - 03/2014
2	C-Reactive ProteinIBA 11/2018 - 11/2018
2	bedaquiline (R207910)IBA 12/2017 - 10/2016
2	Antiviral Agents (Antivirals)IBA 01/2011 - 01/2007
1	COVID-19 VaccinesIBA 06/2022
1	insulin receptor-related receptor (IRR)IBA 12/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Fibrinogen (Factor I)FDA Link 11/2018
1	Oraconal (Serial C)IBA 11/2018
1	fibrin fragment D (D-dimer)IBA 11/2018
1	Hemoglobins (Hemoglobin)IBA 11/2018
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	rifapentine (Priftin)FDA Link 01/2018
1	Combined VaccinesIBA 01/2018
1	Conjugate VaccinesIBA 01/2018
1	antineoplaston A10 (A 10)IBA 01/2018
1	InterferonsIBA 11/2017
1	Pyrazinamide FDA LinkGeneric 01/2017
1	FluoroquinolonesIBA 01/2017
1	BCG Vaccine FDA Link 05/2012
1	Tuberculosis VaccinesIBA 10/2008
1	Antitubercular AgentsIBA 06/2008
1	Oseltamivir (Tamiflu)FDA Link 01/2007

Therapy/Procedure

20	Therapeutics 12/2020 - 05/2006
3	Drug Therapy (Chemotherapy) 11/2015 - 01/2014
2	Length of Stay 01/2014 - 08/2011
1	Mass Drug Administration 01/2021
1	Secondary Prevention 01/2020
1	Transcutaneous Electric Nerve Stimulation (TENS) 10/2018
1	Chemoprevention 01/2017
1	Injections 08/2010